Future roles for FoxM1 inhibitors in cancer treatments. (Q53572906)

15 May 2018

editorial

0 references

title

Future roles for FoxM1 inhibitors in cancer treatments. (English)

1 reference

15 May 2018

author name string

Guy R Adami

series ordinal

1

1 reference

15 May 2018

Honggang Ye

series ordinal

2

1 reference

15 May 2018

language of work or name

English

0 references

publication date

1 February 2007

1 reference

15 May 2018

published in

Future Oncology

1 reference

15 May 2018

volume

3

1 reference

15 May 2018

issue

1

1 reference

15 May 2018

page(s)

1-3

1 reference

15 May 2018

Identification and validation of commonly overexpressed genes in solid tumors by comparison of microarray data

cites work

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.1.1

Loss of the forkhead transcription factor FoxM1 causes centrosome amplification and mitotic catastrophe

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.1.1

FoxM1 is required for execution of the mitotic programme and chromosome stability

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.1.1

Forkhead box M1 regulates the transcriptional network of genes essential for mitotic progression and genes encoding the SCF (Skp2-Cks1) ubiquitin ligase

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.1.1

Increased levels of the FoxM1 transcription factor accelerate development and progression of prostate carcinomas in both TRAMP and LADY transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.1.1

The Forkhead Box m1 transcription factor stimulates the proliferation of tumor cells during development of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.1.1

Foxm1b transcription factor is essential for development of hepatocellular carcinomas and is negatively regulated by the p19ARF tumor suppressor

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.1.1

Liver tumor development. c-Jun antagonizes the proapoptotic activity of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.1.1

Activation of apoptosis in vivo by a hydrocarbon-stapled BH3 helix

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.1.1

A cell-penetrating ARF peptide inhibitor of FoxM1 in mouse hepatocellular carcinoma treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.1.1

Identification of a chemical inhibitor of the oncogenic transcription factor forkhead box M1.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.1.1

Drugging cell cycle kinases in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.1.1

Targeting polo-like kinase 1 for cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.1.1

21 January 2018

Identifiers

DOI

10.2217/14796694.3.1.1

1 reference

15 May 2018

1 reference

15 May 2018